Skip to main content Skip to navigation
Washington State University
Pharmacy and Pharmaceutical Sciences Faculty & Student Scholarship

November 2021 Updates

Pharmaceutical Sciences Assistant Professor Travis T. Denton and three co-authors published “The metabolic importance of the overlooked asparaginase II pathway,” in Analytical Biochemistry, a peer-reviewed journal by Elsevier. Travis Denton and 4-co-authors published, “The metabolic importance of the glutaminase II pathway in normal and cancerous cells,” in Analytical Biochemistry, a peer-reviewed journal by Elsevier. Pharmacotherapy Associate Professor and Director for the Center for Pharmacy Practice Research Kimberly McKeirnan and ten co-authors published, “Advancing a global pharmacy support workforce through a global strategic platform,” in the Journal of Research in Social and Administrative Pharmacy in October 2021. » More ...

October 2021 Updates

FACULTY SCHOLARSHIP

Publications

Boeing Distinguished Professor of Pharmaceutical Sciences Philip Lazarus, Pharmaceutical Sciences Associate in Research Christy Watson and two other co-authors published, “Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions” in Drug Metabolism and Disposition in September 2021.

Philip Lazarus, Christy Watson, Pharmaceutical Sciences Associate Professor Gang Chen and three other co-authors published, “Inhibition of UDP-glucuronosyltransferase enzymes by major cannabinoids and their metabolites,” in Drug Metabolism and Disposition in September 2021.

Allen I. White Distinguished Associate Professor of Pharmacotherapy Joshua Neumiller and four co-authors published, “Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve … » More …

September 2021 Updates

FACULTY SCHOLARSHIP

Publications

J. Roberts and Marcia Fosberg Distinguished Regents Professor of Pharmacotherapy and Director of the Drug Information Center Danial Baker published, “published, “Drug evaluation – sotorasib (Lumakras),” in Wolters Kluwer Health’s The Formulary Monograph Service (FMS) in August 2021. Wolters Kluwer Health is a drug and health information publisher, the FMS is a resource used in the formulary decision making process for hospitals and managed care systems on recently released and investigational drugs.

Danial Baker published, “Drug evaluation – amivantamab -vmyw (Rybrevant),” in the FMS in August 2021.

Danial Baker and Pharmacotherapy Clinical Professor and Director of Quality Assurance Improvement & Accreditation Preparation Terri Levien … » More …

August 2021 Updates

FACULTY SCHOLARSHIP

Publications

J. Roberts and Marcia Fosberg Distinguished Regents Professor of Pharmacotherapy and Director of the Drug Information Center Danial Baker published, “Drug evaluation – tirbanibulin 1% ointment (Klisyri),” in Wolters Kluwer Health’s The Formulary Monograph Service (FMS) in April 2021. Wolters Kluwer Health is a drug and health information publisher, the FMS is a resource used in the formulary decision making process for hospitals and managed care systems on recently released and investigational drugs.

Jing Wang (PharmD class of 2021), Drug Information Center Resident Brittany Craft and Danial Baker published, “Drug evaluation – relugolix (Orgovyx),” in the FMS in April 2021.

Brittany Craft and Danial Baker published, “Drug … » More …

May 2021 Updates

FACULTY SCHOLARSHIP

Publications

Pharmacotherapy Associate Professor and Director for the Center for Pharmacy Practice Research Kimberly McKeirnan and five co-authors published, “Improving pneumococcal vaccination rates among rural older adults through academic detailing: medicine, nursing and pharmacy partnership,” in the Molecular Diversity Preservation International (MDPI) Journal in March 2021.

Research Fellow Sorosh Kherghehpoush and Kimberly McKeirnan published, “Pharmacist-led HIV and hepatitis C point-of-care testing and risk mitigation counseling in individuals experiencing homelessness,” in Elsevier’s March 2021 Exploratory Research in Clinical and Social Pharmacy Journal.

Kimberly McKeirnan, Vice Chair and Allen I. White Distinguished Associate Professor of Pharmacotherapy Joshua Neumiller and one co-author published, “» More …

April 2021 Updates

FACULTY SCHOLARSHIP

Publications

Pharmacotherapy Associate Professor Kimberly McKeirnan, Pharmacotherapy Associate Professor Megan Undeberg and two co-authors published, “A case of pharmacist-led care team interventions to maximize rural patient quality of life,” in the Exploratory Research in Clinical and Social Pharmacy Journal in March 2021.

Pharmacotherapy Assistant Professor Cheyenne Newsome and one co-author published, “Strategies to bring transgender and non-binary healthcare into pharmacy education,” in the American Journal of Pharmaceutical Education in February 2021.

Presentations

Cheyenne Newsome presented on transgender patient care at the American Pharmacists Association (APhA) virtual Annual Meeting in the student programming track on March 14, 2021.

Service

Vice Chair & … » More …

March 2021 Updates

FACULTY SCHOLARSHIP

Publications

United States Transuranium and Uranium Registries (USTUR) Postdoctoral Research Associate Martin Šefl, USTUR Assistant Professor Maia Avtandilashvili, USTUR Director and Professor Sergei Tolmachev, ”Inhalation of soluble plutonium: 53-year follow up of Manhattan project worker,” in Health Physics in February 2021.

Pharmacotherapy Assistant Professor Taylor Bertsch, Pharmaceutical Sciences Assistant Professor Travis Denton, Pharmacotherapy Assistant Professor Nicole Perea (Rodin), Pharmaceutical Sciences Assistant Professor Ayesha Ahmed and Pharmacotherapy Associate Professor Kimberly McKeirnan published, “Drug development and the process of transitioning to team-based learning in a qualitative way,” in the peer-reviewed journal Currents in Pharmacy Teaching and Learning in February 2021.

Kimberly McKeirnan and … » More …

February 2021 Updates

FACULTY SCHOLARSHIP

Publications

Allen I. White Distinguished Associate Professor Josh Neumiller and co-authors published a book chapter titled, “Inflammatory mechanisms in diabetic kidney disease,” in the section, “Obesity and Diabetes,” in Faintuch and Faintuch’s second edition of Obesity and Diabetes Scientific Advances and Best Practice, pp. 437-455.

Josh Neumiller and co-authors published, “Update on the evolving role of GLP-1 receptor agonists in the management of Type 2 diabetes (Audio-enriched Monograph),” on December 30, 2020 on PowerPak’s Continuing Education for Pharmacists & Pharmacy Technicians website.

Josh Neumiller and co-authors published, “Clinical evidence and proposed mechanisms for cardiovascular and kidney benefits from glucagon-like peptide-1 … » More …

December 2020 Updates

FACULTY SCHOLARSHIP

Publications

Allen I. White Distinguished Associate Professor of Pharmacotherapy Joshua Neumiller and co-authors published, “Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence,” in the Nature Reviews November 2020 edition of the Nephrology Journal.

Pharmaceutical Sciences Research Associate (Z. Wang lab) Jin Gao, Pharmaceutical Sciences Associate Professor Zhenjia Wang and four co-authors published , “Co-delivery of resolving D1and antibiotics with nanovesicles to lungs resolves inflammation and clears bacteria in mice,” in the Communications Biology, a peer-reviewed open-access resource from the SpringerNature.

Pharmaceutical Sciences Associate Professor Bhagwat Prasad and two co-authors published, “Utility of Quantitative Proteomics for Enhancing the … » More …

November 2020 Updates

FACULTY SCHOLARSHIP

Presentations

Allen I. White Distinguished Associate Professor of Pharmacotherapy Joshua Neumiller and co-presenters lead a virtual town hall titled, “Focus on the evolving role of GLP-1 receptor agonists,” for Postgraduate Healthcare Education on October 15, 2020. The topic examined the role of GLP-1 receptor agonists in the management of Type 2 diabetes is continually evolving, challenging pharmacists to stay current with the latest science.

Service

Josh Neumiller served on the Steering Committee for the IDEA 2.0: Innovating Decisions and Empowering Action in Diabetes Management program on use of continuous glucose monitors (CGM) sponsored by the American Association of Clinical Endocrinology (AACE).
… » More …